The rebirth of ecancer.org within the new charity ecancer Global Foundation is a timely moment for Eduardo Cazap, the distinguished medical oncologist from Argentina, to take control of the journal. And few folk are as global as he, having been president of UICC, among many other prestigious appointments!
The new emphasis of ecancer.org is on cancer research in and from emerging countries, who sadly are realising that cancer is no longer a disease of rich nations. One death every 8 minutes [1] from cancer of the cervix in India, and the dominance of hepatoma in the cancer incidence tables in Africa are not new observations, but breast, prostate, lung and colorectal malignancies are steadily climbing, unchallenged by national cancer plans, in low-and middle-income countries [2] . So an expert in the field like Eduardo will do a great job leading ecancer through the next decade. Welcome from the ecancer team, who have brought about the success of our journal, and who are keen to work with you in the coming years.
'Knowledge should be free' was the overriding slogan which Umberto Veronesi, my co-founder, and I adopted when we set up the charity the ecancermedicalscience Foundation as publisher of the first ever open access peer reviewed online cancer journal with no publication charges. ecancer has defied the predictions that knowledge could never be free and the first threatening lawyer's letter from a multimillion dollar medical publisher was the icing on the cake! Sadly, Umberto didn't live to share in the tenth anniversary but would have been justly proud of its achievements. These include 50,000 downloads from PubMed Central each month, 21,000 members, an editorial board of 138 distinguished scientists and clinicians, the largest library of Key Opinion Leader oncology video interviews in the world, and around 20 million visits in 12 years from 101 countries.
Education is germane to ecancer, with its collection of free open access online educational courses addressing all healthcare professionals and covering old and new technologies, from palliative care in Sub-Saharan Africa, to HPV vaccination in India and immunooncology in Europe. These multi-lingual video modules help improve patient outcomes and we have evidence that they have been extremely effective. The UICC asked us to prepare and publish their universal TNM classification for the top cancers, to facilitate easy access of clinicians and nurses on a daily basis, and this too has been widely applauded.
But patients need educating too, and ecancerpatient has just reached puberty, with thousands of visits to watch interviews from experts interspersed with explanations of words 2 camouflaged by 'doctor-speak'. Education should be 'blended' according to the evidence, so ecancer has run teaching 'face-to-face' meetings in several continents, and most unusually on 11 occasions in Latin America, in Spanish.
